Analgesics in the Netherlands

Date: September 19, 2016
Pages: 32
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A9544652252EN
Leaflet:

Download PDF Leaflet

Analgesics are amongst the most commonly used OTC products used in the Netherlands. In 2016, current value sales of analgesics increased by 1% in the Netherlands, to reach €105 million. Analgesics are available through a wide range of distribution channels, including supermarkets, drugstores/parapharmacies, petrol stations and chemists/pharmacies. A large number of consumers use analgesics such as ibuprofen and acetaminophen when the first symptoms of illness appear. The increase in sales in 201...

Euromonitor International's Analgesics in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Analgesics by Category: Value 2011-2016
  Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
  Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
  Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
  Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Bayer Consumer Care BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
  Summary 1 Bayer Consumer Care BV: Key Facts
  Summary 2 Bayer Consumer Care BV: Operational Indicators
Competitive Positioning
  Summary 3 Bayer Consumer Care BV: Competitive Position 2016
Omega Pharma Nederland BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
  Summary 4 Omega Pharma Nederland BV: Key Facts
  Summary 5 Omega Pharma Operational Indicators
Competitive Positioning
  Summary 6 Omega Pharma Nederland BV: Competitive Position 2016
Pfizer BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
  Summary 7 Pfizer BV: Key Facts
  Summary 8 Pfizer BV: Operational Indicators
Competitive Positioning
  Summary 9 Pfizer BV: Competitive Position 2016
Remark Pharma BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
  Summary 10 Remark Pharma BV: Key Facts
  Summary 11 Remark Pharma BV: Key Facts
Competitive Positioning
  Summary 12 Remark Pharma BV: Key Facts
Vemedia BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
  Summary 13 Vemedia BV: Key Facts
  Summary 14 Vemedia BV: Operational Indicators
Competitive Positioning
  Summary 15 Vemedia BV: Competitive Position 2016
Executive Summary
Consumer Health Records A Positive Value Performance in 2016
the Weather Conditions Fuel Sales in Consumer Health
Companies Join Forces To Strengthen Their Positions in Consumer Health
Retail Environment Is Changing Due To Changing Consumer Patterns
Consumer Health Is Expected To Experience Moderate Value Growth Over the Forecast Period
Key Trends and Developments
Consumers Are Adopting Healthy Lifestyles
the Ageing Population in the Netherlands
A Shift in Focus Away From Treatment Towards Prevention
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
  Table 9 Life Expectancy at Birth 2011-2016
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2011-2016
  Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
  Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
  Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
  Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
  Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 16 OTC: Switches 2014-2016
Sources
  Summary 17 Research Sources












Skip to top


Analgesics - Netherlands US$ 990.00 Jun, 2010 · 35 pages
Adult Mouth Care in the Netherlands US$ 990.00 Sep, 2016 · 20 pages
Calming and Sleeping in the Netherlands US$ 990.00 Apr, 2015 · 22 pages

Ask Your Question

Analgesics in the Netherlands
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: